J. Scott Wolchko
2020
In 2020, J. Scott Wolchko earned a total compensation of $5.6M as President, Chief Executive Officer and Director at Fate Therapeutics, a 48% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $356,250 |
|---|---|
| Option Awards | $3,222,577 |
| Salary | $570,000 |
| Stock Awards | $1,451,340 |
| Total | $5,600,167 |
Wolchko received $3.2M in option awards, accounting for 58% of the total pay in 2020.
Wolchko also received $356.3K in non-equity incentive plan, $570K in salary and $1.5M in stock awards.
Rankings
In 2020, J. Scott Wolchko's compensation ranked 1,917th out of 13,090 executives tracked by ExecPay. In other words, Wolchko earned more than 85.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,917 out of 13,090 | 85th |
Division Manufacturing | 744 out of 5,621 | 87th |
Major group Chemicals And Allied Products | 269 out of 2,254 | 88th |
Industry group Drugs | 226 out of 1,954 | 88th |
Industry Biological Products, Except Diagnostic Substances | 66 out of 411 | 84th |
Source: SEC filing on April 21, 2021.
Wolchko's colleagues
We found four more compensation records of executives who worked with J. Scott Wolchko at Fate Therapeutics in 2020.